Yes, naltrexone blocks most of kratom’s opioid-like effects. Naltrexone occupies the same mu-opioid receptors that kratom’s active compounds bind to, and it does so with much stronger affinity. In animal studies, naltrexone fully reversed the pain-relieving effects of kratom’s key alkaloids, including mitragynine, 7-hydroxymitragynine, speciociliatine, and corynoxine. If you take naltrexone while kratom is still active in your body, you risk triggering precipitated withdrawal, a rapid and intense onset of withdrawal symptoms.
How Naltrexone Blocks Kratom at the Receptor Level
Kratom produces its opioid-like effects primarily through two alkaloids: mitragynine (the most abundant) and 7-hydroxymitragynine (the most potent). Both bind to the mu-opioid receptor, the same target that drugs like morphine and oxycodone act on. 7-hydroxymitragynine is the stronger of the two, with a binding affinity (Ki) as low as 7 nM in some measurements, making it roughly 20 times more attracted to the receptor than mitragynine, which ranges from about 160 to 230 nM depending on the study.
Naltrexone is a competitive antagonist at the mu-opioid receptor, meaning it latches onto the receptor and physically prevents other compounds from activating it. Its binding affinity is substantially stronger than any of kratom’s alkaloids. In practical terms, naltrexone wins the competition for the receptor every time. Research published in Frontiers in Pharmacology confirmed that naltrexone fully antagonized the pain-killing effects of mitragynine, 7-hydroxymitragynine, speciociliatine, corynoxine, and morphine in animal models.
One nuance worth knowing: mitragynine has complex pharmacology. At the human mu-opioid receptor in lab settings, it actually behaves as an antagonist (blocking the receptor rather than activating it), while in live animals it produces opioid-like effects, likely because the body converts some mitragynine into 7-hydroxymitragynine. Naltrexone blocked the opioid-related behavioral effects of mitragynine in rats but did not block all of its other actions, such as its ability to slow physical activity. This suggests kratom has some effects that don’t run through opioid receptors and that naltrexone won’t touch.
What Precipitated Withdrawal Looks Like
If you’ve been using kratom regularly and take naltrexone before the kratom alkaloids have cleared your system, naltrexone can rip those compounds off your opioid receptors all at once. This triggers precipitated withdrawal, which is the same phenomenon seen when naltrexone is given to someone still using traditional opioids, but it catches many people off guard because they don’t think of kratom as an opioid.
Precipitated withdrawal comes on fast, typically within minutes to hours of taking naltrexone, rather than the gradual onset of normal withdrawal. Symptoms can include severe nausea, vomiting, diarrhea, muscle aches, sweating, anxiety, agitation, and rapid heart rate. A published case report in The Mental Health Clinician described a patient who experienced precipitated withdrawal after receiving naltrexone without having disclosed chronic kratom use. The withdrawal was unexpected by the treatment team precisely because kratom wasn’t on their radar as an opioid-like substance.
To avoid this, the standard recommendation is to be opioid-free for a minimum of 7 to 10 days before starting naltrexone. This applies to kratom as well, even though it’s sold as an herbal supplement. The exact clearance time depends on how much kratom you’ve been using, how long you’ve used it, and your individual metabolism.
Pain Relief, Euphoria, and What Gets Blocked
Naltrexone blocks the effects of kratom that work through opioid receptors. This includes pain relief (the analgesic effect), the warm euphoria or mood lift that many kratom users seek, and the sedation that comes with higher doses. In rodent studies, naltrexone at a dose of just 0.1 mg/kg delivered intravenously was enough to fully reverse the pain-blocking effects of multiple kratom alkaloids.
What naltrexone likely does not block are kratom’s non-opioid effects. Kratom alkaloids also interact with adrenergic receptors, serotonin receptors, and other systems. The stimulant-like effects people report at low kratom doses, such as increased energy and alertness, may partially escape naltrexone’s blockade. However, the opioid effects are generally what people using kratom at moderate to high doses are experiencing most prominently, and those will be effectively shut down.
Liver Safety Concerns
Both kratom and naltrexone carry independent risks to the liver, which makes their combination or sequential use worth paying attention to. Kratom has been linked to rare cases of acute liver injury, with case reports showing liver enzyme levels rising to 4 to 10 times the upper limit of normal. Naltrexone also carries a warning for potential liver enzyme elevations, though at standard doses the risk is considered low.
In one documented case, a patient developed significant liver inflammation (AST of 173 U/L and ALT of 586 U/L) attributed primarily to kratom use. Naltrexone was later administered and triggered precipitated withdrawal on top of the existing liver problem. A formal analysis using the Naranjo adverse drug reaction scale rated kratom as the probable cause of the liver damage (score of 6) and naltrexone as doubtful (score of 0). Still, the potential for additive liver stress exists when these substances overlap, especially in people with preexisting liver conditions or heavy kratom use.
Naltrexone for Kratom Dependence
Because naltrexone blocks kratom’s rewarding opioid effects, it has been used in clinical settings to help people stop using kratom, following the same logic as naltrexone treatment for alcohol or opioid use disorders. By eliminating the “payoff” from kratom, naltrexone can reduce cravings and make relapse less reinforcing.
The evidence base here is still limited to case reports rather than large clinical trials, but the pharmacology supports it clearly: if naltrexone is occupying your opioid receptors, kratom simply cannot produce its usual effects. The injectable form of naltrexone, which lasts about a month, removes the daily decision of whether to take a pill, which can be helpful for people trying to quit.
The critical step is getting through the washout period. You need to stop kratom for at least 7 to 10 days before receiving naltrexone. During that window, you’ll go through standard kratom withdrawal, which for regular users typically involves irritability, muscle aches, insomnia, runny nose, and mood changes. Trying to shortcut this timeline is what leads to precipitated withdrawal, which is significantly more uncomfortable and can require medical attention.
Low-Dose Naltrexone: A Different Situation
Low-dose naltrexone (LDN), typically taken at 1 to 5 mg compared to the standard 50 mg, is used for a variety of conditions including chronic pain and autoimmune disorders. At these lower doses, naltrexone provides only brief, partial blockade of opioid receptors rather than the sustained full blockade of a standard dose. There is no published research specifically examining the interaction between LDN and kratom. However, the same receptor competition applies on a smaller scale. LDN could still partially block kratom’s effects and, in someone with physical dependence, could potentially trigger a milder version of precipitated withdrawal. The lack of specific data means this is an area where caution matters more than usual.